Meatable key facts
- Developer of a stem cell technology designed to manufacture cultured meat.
- It has raised $148.6M; the latest was Later Stage VC in Nov 2024.
- Notable investors include GV, European Commission, Charles Songhurst, Hawktail, Possible Ventures — 30 tracked in total.
- Status: Privately Held (backing).
Who backs Meatable
30+- ·The complete investor list: 30 names
- ·Watch Meatable: the Monday email on marks, rounds and moves
Meatable funding rounds
No funding rounds for Meatable are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Meatable investors
30 investors are on record for Meatable, including GV, European Commission, Charles Songhurst and Hawktail. By type, the record holds 5 venture capital firms and 2 private investors.
About Meatable
Developer of a stem cell technology designed to manufacture cultured meat. The company's technology eliminates the need to remove any tissue from an animal by using pluripotent stem cells, which possess the ability to turn any type of cell from muscle to fat without serum, enabling consumers to have efficient, sustainable, and delicious food.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Leiden, Netherlands
- Founded
- 2018
- Employees
- 90
- Website
- meatable.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Meatable doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.